Ashwin Sridharan

454 total citations
17 papers, 308 citations indexed

About

Ashwin Sridharan is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ashwin Sridharan has authored 17 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 7 papers in Genetics and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ashwin Sridharan's work include Acute Myeloid Leukemia Research (6 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Adolescent and Pediatric Healthcare (3 papers). Ashwin Sridharan is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Adolescent and Pediatric Healthcare (3 papers). Ashwin Sridharan collaborates with scholars based in United States, Netherlands and United Kingdom. Ashwin Sridharan's co-authors include Amit Verma, Ulrich Steidl, Baoxia Dong, Boris Bartholdy, Gaurav S. Choudhary, Andrea López, Thomas P. Garner, Denis E. Reyna, Swathi-Rao Narayanagari and Loren D. Walensky and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ashwin Sridharan

16 papers receiving 301 citations

Peers

Ashwin Sridharan

ONCOL

HEMAT

GENET

RNMI

Joanna Trelińska Poland

Theodoros Marinakis Greece

Rajesh Belani United States

Fernando Vieira Pericole Brazil

Nazir Jamal Canada

Amandeep Godara United States

Jessica Boklan United States

Fred Hardwicke United States

Michelle E. Maglio United States

R. Mauritz Netherlands

Joanna Trelińska Poland

Ashwin Sridharan

172 ×1.3

199 ×2.1

ONCOL

70 ×0.9

HEMAT

40 ×0.9

GENET

13 ×0.4

RNMI

Citations per year, relative to Ashwin Sridharan Ashwin Sridharan (= 1×) peers Joanna Trelińska

Countries citing papers authored by Ashwin Sridharan

Since Specialization

Citations

This map shows the geographic impact of Ashwin Sridharan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwin Sridharan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwin Sridharan more than expected).

Fields of papers citing papers by Ashwin Sridharan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashwin Sridharan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwin Sridharan. The network helps show where Ashwin Sridharan may publish in the future.

Co-authorship network of co-authors of Ashwin Sridharan

This figure shows the co-authorship network connecting the top 25 collaborators of Ashwin Sridharan. A scholar is included among the top collaborators of Ashwin Sridharan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashwin Sridharan. Ashwin Sridharan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Faiz, Ambarina S., Shuang Guo, Ashwin Sridharan, Yong Lin, & Claire S. Philipp. (2024). Risk factors and mortality associated with venous thromboembolism in the elderly US population with chronic lymphocytic leukemia. Leukemia Research. 146. 107585–107585.

Faiz, Ambarina S., Shuang Guo, Ashwin Sridharan, Yong Lin, & Claire S. Philipp. (2023). Venous thromboembolism and acute myeloid leukemia: risk factors and mortality in elderly white, black and Asian patients. Blood Coagulation & Fibrinolysis. 34(6). 345–352. 5 indexed citations

Aluri, Srinivas, Marc Ruíz-Martínez, Ashwin Sridharan, et al.. (2023). Iron chelation improves ineffective erythropoiesis and iron overload in myelodysplastic syndrome mice. eLife. 12. 5 indexed citations

Faiz, Ambarina S., Ashwin Sridharan, Shuang Guo, Yong Lin, & Claire S. Philipp. (2023). Risk factors and mortality associated with venous thromboembolism in the elderly US population with acute lymphocytic leukemia. SHILAP Revista de lepidopterología. 14. 100155–100155. 2 indexed citations

Viola, Adrienne, Richard A. Drachtman, Ashwin Sridharan, et al.. (2021). Feasibility of Medical Student Mentors to Improve Transition in Sickle Cell Disease. Journal of Pediatric Psychology. 46(6). 650–661. 2 indexed citations

Viola, Adrienne, et al.. (2020). Utilizing Medical Students As Patient Mentors: An Intervention to Improve Transition Readiness in Young Adults with Sickle Cell Disease. Blood. 136(Supplement 1). 34–35. 1 indexed citations

Viola, Adrienne, Richard A. Drachtman, Jerlym S. Porter, et al.. (2020). Understanding Barriers to Transition From Pediatric to Adult Care Among Young Adults With Sickle Cell Disease to Develop a Transition Mentor Program. Clinical Practice in Pediatric Psychology. 9(1). 68–81. 9 indexed citations

Santini, Valeria, David Valcárcel, Uwe Platzbecker, et al.. (2019). Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes. Clinical Cancer Research. 25(23). 6976–6985. 60 indexed citations

Thibaud, Santiago, Yanhua Wang, Murali Janakiram, et al.. (2019). HIV portends a poor prognosis in myelodysplastic syndromes. Leukemia & lymphoma. 60(14). 3529–3535. 11 indexed citations

10.

Reyna, Denis E., Thomas P. Garner, Andrea López, et al.. (2017). Direct Activation of BAX by BTSA1 Overcomes Apoptosis Resistance in Acute Myeloid Leukemia. Cancer Cell. 32(4). 490–505.e10. 120 indexed citations

11.

Thibaud, Santiago, Ashwin Sridharan, Amer Assal, et al.. (2016). HIV Is Associated with a High Rate of Unexplained Multilineage Cytopenias and Portends a Poor Prognosis in Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML). Blood. 128(22). 4345–4345. 4 indexed citations

12.

Assal, Amer, Ashwin Sridharan, Aditi Shastri, et al.. (2015). Analysis of a large single center cohort demonstrates poor prognosis of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in HIV infected patients (pts).. Journal of Clinical Oncology. 33(15_suppl). e18077–e18077. 1 indexed citations

13.

Sridharan, Ashwin, Rishi Jain, Marcus A. Bachhuber, et al.. (2014). Epidemiologic study of myelodysplastic syndromes in a multiethnic, inner city cohort. Experimental Hematology and Oncology. 3(1). 22–22. 6 indexed citations

14.

Alexis, Karenza, et al.. (2014). Acquired Von Willebrand’s Syndrome in Systemic Lupus Erythematosus. SHILAP Revista de lepidopterología. 2014. 1–7. 8 indexed citations

15.

Gundabolu, Krishna, Ashwin Sridharan, Rishi Jain, et al.. (2013). Multiplicative interaction between mean corpuscular volume and red cell distribution width in predicting mortality of elderly patients with and without anemia. American Journal of Hematology. 88(11). E245–9. 36 indexed citations

16.

Gundabolu, Krishna, Ashwin Sridharan, Rishi Jain, et al.. (2012). Multiplicative Interaction Between Mean Corpuscular Volume and Red Cell Distribution Width in Predicting Mortality of Elderly Patients with and without Anemia. Blood. 120(21). 5150–5150. 3 indexed citations

17.

Boghaert, Erwin R., Kiran Khandke, Latha Sridharan, et al.. (2006). Tumoricidal effect of calicheamicin immuno-conjugates using a passive targeting strategy. International Journal of Oncology. 28(3). 675–84. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact